tetano
Editor, Senior Moderator
European CHMP adopts positive opinion on pandemic influenza vaccine (H5N1) Pumarix?
Source: European Medicines Agency (EMA)
Date published: 19/11/2010 17:37
Summary
by: Yuet Wan
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a marketing authorisation for Pumarix? [pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)], intended for prophylaxis of influenza in an officially declared pandemic situation. Pumarix is a mock-up vaccine, which means that the current strain can be changed to the pandemic strain once identified.
http://www.nelm.nhs.uk/en/NeLM-Area...-on-pandemic-influenza-vaccine-H5N1-Pumarix-/
Source: European Medicines Agency (EMA)
Date published: 19/11/2010 17:37
Summary
by: Yuet Wan
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a marketing authorisation for Pumarix? [pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)], intended for prophylaxis of influenza in an officially declared pandemic situation. Pumarix is a mock-up vaccine, which means that the current strain can be changed to the pandemic strain once identified.
http://www.nelm.nhs.uk/en/NeLM-Area...-on-pandemic-influenza-vaccine-H5N1-Pumarix-/